Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,288 | 83 | 99.6% |
| Education | $5.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $277.08 | 23 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $171.48 | 7 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $130.37 | 11 | $0 (2018) |
| Novo Nordisk Inc | $108.56 | 6 | $0 (2018) |
| Indivior Inc. | $98.88 | 1 | $0 (2018) |
| Mission Pharmacal Company | $82.25 | 6 | $0 (2018) |
| Amarin Pharma Inc. | $76.07 | 4 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $65.44 | 5 | $0 (2018) |
| Orexigen Therapeutics, Inc. | $39.58 | 3 | $0 (2018) |
| PFIZER INC. | $39.47 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $8.69 | 1 | Organon LLC ($8.69) |
| 2018 | $563.64 | 34 | GlaxoSmithKline, LLC. ($173.63) |
| 2017 | $720.50 | 49 | AstraZeneca Pharmaceuticals LP ($155.90) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/06/2022 | Organon LLC | JADA SYSTEM (Device) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: POSTPARTUM UTERINE HEMORRHAGING | ||||||
| 09/12/2018 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: VACCINES | ||||||
| 08/31/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Diabetes | ||||||
| 08/28/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Hypertriglyceridemia | ||||||
| 08/14/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Diabetes | ||||||
| 08/09/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2018 | Nalpropion Pharmaceuticals, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Obesity | ||||||
| 07/31/2018 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Hypertriglyceridemia | ||||||
| 07/24/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2018 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.50 | General |
| 07/16/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR ORAL (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/06/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Diabetes | ||||||
| 06/05/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR ORAL (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/09/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: RESPIRATORY | ||||||
| 04/26/2018 | Acclarent, Inc | ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Rhinology, Otology | ||||||
| 04/24/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: RESPIRATORY | ||||||
| 04/20/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2018 | Mission Pharmacal Company | Prednisolone 25 (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Adrenocorticosteroid | ||||||
| 04/13/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: RESPIRATORY | ||||||
| 04/09/2018 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: RESPIRATORY | ||||||
| 04/06/2018 | Medtronic Vascular, Inc. | ClosureFast (Device) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: EndoVenous Therapies | ||||||
| 03/28/2018 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,083 | 1,381 | $263,253 | $78,717 |
| 2022 | 10 | 846 | 983 | $198,178 | $66,083 |
| 2021 | 5 | 469 | 599 | $80,942 | $46,258 |
| 2020 | 6 | 336 | 434 | $54,978 | $22,022 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 307 | 515 | $105,309 | $31,665 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 335 | 408 | $54,695 | $20,610 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 255 | 255 | $81,837 | $18,743 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $7,950 | $2,903 | 36.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 37 | 37 | $6,771 | $2,805 | 41.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 39 | $2,808 | $1,205 | 42.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 41 | 56 | $2,296 | $533.12 | 23.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 23 | $1,403 | $201.96 | 14.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 21 | 23 | $184.00 | $50.60 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 225 | 320 | $65,782 | $22,252 | 33.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 207 | 207 | $67,950 | $18,726 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 180 | 207 | $28,987 | $12,373 | 42.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 61 | 61 | $11,163 | $4,285 | 38.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $8,904 | $3,492 | 39.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 15 | 17 | $7,973 | $2,395 | 30.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 65 | 65 | $4,680 | $1,960 | 41.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 29 | 40 | $1,640 | $383.20 | 23.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 15 | $915.00 | $165.66 | 18.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 21 | 23 | $184.00 | $50.88 | 27.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 180 | 292 | $38,006 | $19,203 | 50.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 141 | 141 | $23,970 | $18,864 | 78.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 109 | 126 | $12,636 | $5,642 | 44.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 15 | $3,405 | $1,408 | 41.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 25 | 25 | $2,925 | $1,141 | 39.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 133 | 204 | $27,313 | $10,195 | 37.3% |
About Dr. Sara Erickson, M.D
Dr. Sara Erickson, M.D is a Internal Medicine healthcare provider based in Sanford, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356374821.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sara Erickson, M.D has received a total of $1,293 in payments from pharmaceutical and medical device companies, with $8.69 received in 2022. These payments were reported across 84 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,288).
As a Medicare-enrolled provider, Erickson has provided services to 2,734 Medicare beneficiaries, totaling 3,397 services with total Medicare billing of $213,080. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Pediatrics
- Location Sanford, ME
- Active Since 07/08/2006
- Last Updated 08/26/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1356374821
Products in Payments
- FARXIGA (Drug) $140.21
- ANORO (Drug) $122.48
- SUBLOCADE (Drug) $98.88
- TRELEGY ELLIPTA (Drug) $83.93
- Vascepa (Drug) $76.07
- JARDIANCE (Drug) $65.99
- BELSOMRA (Drug) $63.14
- CONTRAVE (Drug) $53.11
- BREO (Drug) $45.49
- PREVNAR - 13 (Biological) $39.47
- Ozempic (Drug) $37.58
- BEVESPI AEROSPHERE (Drug) $31.27
- ClosureFast (Device) $29.91
- JANUMET (Drug) $29.85
- Prednisolone 25 (Drug) $28.32
- Hycofenix (Drug) $27.31
- Uribel (Drug) $26.62
- JANUVIA (Drug) $24.54
- XARELTO (Drug) $22.54
- RELISTOR ORAL (Drug) $22.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sanford
Dr. Luis Correa Luna, Md, MD
Internal Medicine — Payments: $304,068
Manish Saha, Md, MD
Internal Medicine — Payments: $13,597
Haroon Chughtai, M.d, M.D
Internal Medicine — Payments: $8,012
Nguyen Vu, M.d, M.D
Internal Medicine — Payments: $7,186
Rena Mehta, M.d, M.D
Internal Medicine — Payments: $7,050
Dr. Dhruti Chen, Md, MD
Internal Medicine — Payments: $3,898